Stayble Therapeutics AB (publ) (STO:STABL)
Sweden · Delayed Price · Currency is SEK 0.1990
+0.0115 (6.13%)
Apr 9, 2026, 5:18 PM CET
Stayble Therapeutics AB Market Cap
Stayble Therapeutics AB has a market cap or net worth of 12.07 million as of April 9, 2026. Its market cap has decreased by -50.78% in one year.
Market Cap
12.07M
Enterprise Value
10.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
Market Cap Chart
Since March 9, 2020, Stayble Therapeutics AB's market cap has decreased from 66.74M to 12.07M, a decrease of -81.92%. That is a compound annual growth rate of -24.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 12.07M | -16.67% |
| Dec 30, 2025 | 14.48M | -35.06% |
| Dec 30, 2024 | 22.30M | 131.99% |
| Dec 29, 2023 | 9.61M | -82.65% |
| Dec 30, 2022 | 55.39M | -36.71% |
| Dec 30, 2021 | 87.51M | 28.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AcouSort AB | 61.38M |
| Nanologica AB | 44.87M |
| Modus Therapeutics Holding AB | 35.64M |
| 2cureX AB | 27.61M |
| Guard Therapeutics International AB | 27.43M |
| ExpreS2ion Biotech Holding AB | 24.68M |
| Fluicell AB | 19.64M |
| Aptahem AB | 14.93M |